Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 15646657 | HLA-A*24 | stem cell transplantation | NA | NA | NA | unclassified | |
| reconstitution of hla-a*2402-restricted cytomegalovirus-specific t-cells following stem cell transplantation. | |||||||
| 15646657 | HLA-A*24 | stem cell transplantation | NA | NA | NA | unclassified | |
| cytomegalovirus (cmv)-specific immune reconstitution early after stem cell transplantation (sct) was evaluated prospectively by detecting cd8+ t-cells, which recognize the peptide qydpvaalf in the context of hla-a*2402. | |||||||
| 15665841 | HLA-DR (HLA-DR) | stem cell transplantation | NA | NA | NA | only_studied | |
| we examined the recovery of circulating monocytoid (lin- cd11+ hla-dr+) and plasmacytoid (lin- cd123+ hla-dr+) precursor (pre) dendritic cell (dc) subsets after allogeneic stem cell transplantation (sct) in 39 children, using age-matched healthy children as controls. | |||||||
| 15703981 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | positive+negation | |
| considering the severity of the disease, if hla-matched sibling donor is not available, haematopoietic stem cell transplantation using a matched unrelated donor should be strongly considered for treating congenital erythropoietic porphyria since this is currently the only known curative therapy. | |||||||
| 15703981 | HLA MATCHED (HLA-MATCHED) | congenital erythropoietic porphyria | NA | NA | NA | positive+negation | |
| considering the severity of the disease, if hla-matched sibling donor is not available, haematopoietic stem cell transplantation using a matched unrelated donor should be strongly considered for treating congenital erythropoietic porphyria since this is currently the only known curative therapy. | |||||||
| 15727255 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| comprehensive and accurate five-locus hla typing allows confident and rapid identification of potential matched hsc donors for patients requiring stem cell transplantation generally without the need for typing additional loci. | |||||||
| 15823215 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | unclassified | |
| hla-matched embryos selected for siblings requiring haematopoietic stem cell transplantation: a psychological perspective. | |||||||
| 15853897 | HLA-B*44 | stem cell transplantation | European | NA | NA | unclassified | |
| this dataset can therefore be used as a predictive tool for b44- and c-disparities in unrelated stem cell transplantation. | |||||||
| 15946779 | NA (NA) | stem cell transplantation | NA | NA | NA | unclassified | |
| although histocompatibility testing and matching for histocompatibility leukocyte antigens (hla) remains the "state of the art" for determining donor selection, non-hla encoded genes such as those for minor histocompatibiity antigens also play an important role in determining haematopoietic stem cell transplantation (hsct) outcome. | |||||||
| 16129661 | HLA MATCHED (HLA-MATCHED) | foscarnet | NA | cidofovir | NA | negative | |
| NA | |||||||
Copyright 2024